The Effect of Anticoagulation and Antiplatelet Use in Trauma Patients on Mortality and Length of Stay

Abstract

Background

Though many trauma patients are on anticoagulation or antiplatelet therapy (AAT), there are few generalizable data on the risks for these patients. The purpose of this study was to analyze the impact of anticoagulation (AC) and antiplatelet (AP) therapy on mortality and length of stay (LOS) in general trauma patients.

Methods

A retrospective review was performed of patients in the institutional trauma registry during 2019 to determine AAT use on admission and discharge. Outcomes were compared using standard statistics.

Results

Of 2261 patients who met the inclusion criteria, 2 were excluded due to an incomplete medication reconciliation, resulting in 2259 patients. Patients on AAT had a higher mortality (4.5% vs 2.1%). On multivariable analysis, preadmission AC (odds ratio OR, 3.325, P = .001), age (OR 1.040, P < .001), and injury severity score ((ISS) 1.094, P < .001) were associated with mortality. Anticoagulation use was also associated with longer LOS on multivariable analysis (OR: 1.626, P = .005). Antiplatelet use was not associated with higher mortality or longer LOS. More patients on AAT were unable to be discharged home. However, patients on AAT did not have a greater blood transfusion requirement or need more hemorrhage control procedures. Lastly, 23.7% of patients on preadmission AAT were not discharged on any AAT.

Discussion

These data demonstrate that patients on AC, but not AP, have greater mortality and longer hospital LOS. This may provide guidance for those being newly started on AAT. Further work to determine which patients benefit most from restarting AAT would lead to improvement in the care of trauma patients.

Keywords

novel oral anticoagulation direct oral anticoagulation traumatic injury warfarin aspirin

Get full access to this article

View all access options for this article.

References

Holbrook

Simpson

Dowlatshahi

Johnson

. Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: A population-based descriptive analysis. CMAJ Open. Sep 2013;1(3):E115-E119. doi:10.9778/cmajo.20130032.

Hickey

. Anticoagulation management in clinical practice: Preventing stroke in patients with atrial fibrillation. Heart Lung. Mar-Apr 2012;41(2):146-156. doi:10.1016/j.hrtlng.2011.07.008.

Ang

Kurek

McKenney

, et al. Outcomes of geriatric trauma patients on preinjury anticoagulation: A multicenter study. Am Surg. Jun 2017;83(6):527-535.

Coleman

Baldawi

Heidt

. The effect anticoagulation status on geriatric fall trauma patients. Am J Surg. Dec 2016;212(6):1237-1242. doi:10.1016/j.amjsurg.2016.09.036.

Boltz

Podany

Hollenbeak

Armen

. Injuries and outcomes associated with traumatic falls in the elderly population on oral anticoagulant therapy. Injury. Sep 2015;46(9):1765-1771. doi:10.1016/j.injury.2015.06.013.

Chiu

Jean

Fleming

Pei

. Recurrent falls among elderly patients and the impact of anticoagulation therapy. World J Surg. Dec 2018;42(12):3932-3938. doi:10.1007/s00268-018-4728-1.

DiFiori

Lamb

Calavan

Comey

Feeney

. Readmissions in patients with anticoagulated intracranial hemorrhage: A retrospective review. World Neurosurg. Feb 2018;110:e305-e309. doi:10.1016/j.wneu.2017.10.165.

O'Neill

Jean

Savetamal

, et al. When to admit to observation: Predicting length of stay for anticoagulated elderly fall victims. J Surg Res. Jun 2020;250:156-160. doi:10.1016/j.jss.2020.01.006.

Franco

Paciaroni

Enrico

, et al. Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy. Eur J Intern Med. May 2020;75:35-43. doi:10.1016/j.ejim.2019.12.016.

10.

Hall

Essler

Dandashi

, et al. Impact of frailty and anticoagulation status on readmission and mortality rates following falls in patients over 80. Proc (Bayl Univ Med Cent). Apr 2019;32(2):181-186. doi:10.1080/08998280.2018.1550468.

11.

Golob

Sando

Kan

Yowler

Malangoni

Claridge

. Therapeutic anticoagulation in the trauma patient: Is it safe? Surgery. Oct 2008;144(4):591-596. doi:10.1016/j.surg.2008.06.022.

12.

Nielsen

Larsen

Skjøth

Lip

. Outcomes associated with resuming warfarin treatment after hemorrhagic stroke or traumatic intracranial hemorrhage in patients with atrial fibrillation. JAMA Intern Med. Apr 2017;177(4):563-570. doi:10.1001/jamainternmed.2016.9369.

13.

Albrecht

Liu

Baumgarten

, et al. Benefits and risks of anticoagulation resumption following traumatic brain injury. JAMA Intern Med. Aug 2014;174(8):1244-1251. doi:10.1001/jamainternmed.2014.2534.

14.

Puckett

Zhang

Blasingame

, et al. Safest time to resume oral anticoagulation in patients with traumatic brain injury. Cureus. Jul 2018;10(7):e2920. doi:10.7759/cureus.2920.

15.

Won

Dubinski

Bruder

Cattani

Seifert

Konczalla

. Acute subdural hematoma in patients on oral anticoagulant therapy: Management and outcome. Neurosurg Focus. Nov 2017;43(5):E12. doi:10.3171/2017.8.FOCUS17421.

16.

Staerk

Fosbøl

Lip

GYH

, et al. Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: A nationwide cohort study. Eur Heart J. Mar 2017;38(12):907-915. doi:10.1093/eurheartj/ehw496.

17.

Maung

Bhattacharya

Schuster

Davis

. Trauma patients on new oral anticoagulation agents have lower mortality than those on warfarin. J Trauma Acute Care Surg. Oct 2016;81(4):652-657. doi:10.1097/TA.0000000000001189.

18.

Feeney

Neulander

DiFiori

, et al. Direct oral anticoagulants compared with warfarin in patients with severe blunt trauma. Injury. Jan 2017;48(1):47-50. doi:10.1016/j.injury.2016.08.016.

19.

Turcato

Zannoni

Zaboli

, et al. Direct oral anticoagulant treatment and mild traumatic brain injury: Risk of early and delayed bleeding and the severity of injuries compared with vitamin K antagonists. J Emerg Med. Dec 2019;57(6):817-824. doi:10.1016/j.jemermed.2019.09.007.